Journal
CANCER LETTERS
Volume 447, Issue -, Pages 41-47Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2019.01.015
Keywords
Gut microbiome; Cancer; Immunity; Cancer immunotherapy
Categories
Funding
- Young Scientists Fund of the National Natural Science Foundation of China [81202095]
- Natural Science Foundation of Hubei Province [2016CFB136, 2016CFB550]
Ask authors/readers for more resources
Microbiome is becoming crucial in that the balance between human health and disease can be mediated by the gut microbiome. The gut microbiome can modulate the host immune system both locally and systemically. Cancer immunotherapy has emerged as a promising way in the treatment of patients with cancer. Accumulating evidence supports that microbiome affects the therapeutic efficacy of cancer immunotherapy, particularly immune checkpoint inhibitors. Here, we discuss the mutual relationship among gut microbiome, cancer, immunity, and cancer immunotherapy, with a focus on immunotherapy. Also, we briefly introduce the relevant challenges that affect the therapeutic efficacy and present the possible solutions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available